Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric

09 Mar 20264 min read0 viewsJournal Feed

GIST (Key Takeaways)

Circulation, Ahead of Print. BACKGROUND:Sarcomere gene variants are a key cause of hypertrophic cardiomyopathy (HCM), and have been associated with worse prognosis.
However, it is unclear how comorbidities influence clinical trajectories, the timing of events, and causes of death in sarcomeric and nonsarcomeric HCM.METHODS:We conducted a multicenter longitudinal cohort study of genotyped patients with HCM in the Sarcomeric Human Cardiomyopathy registry (SHaRe). Patients were classified as sarcomeric HCM (pathogenic/likely pathogenic sarcomere variant) or nonsarcomeric HCM (genetically elusive).
The influence of genetic classification and comorbidities on the sequence of cardiovascular events were assessed in time-varying Cox proportional hazards models. RESULTS:Among 6120 patients (40% women; 87% probands; 50% sarcomeric HCM), followed for a median of 5.3 years, sarcomeric HCM (n=3082) was associated with a younger age at diagnosis (median 38.1 versus 54.3 years;P<0.001), a higher proportion of women and less obesity, hypertension, and left ventricular (LV) obstruction.

Circulation published a clinical update in Cardiology on 09 Mar 2026.

The item focuses on Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic Cardiomyopathy.

Review the original article for the full source wording and details.

Read the full original publication from the source journal or publisher link below.

Feed Metadata

Source

Circulation